RAC media coverage, page-2219

First 2219 Last

Share
Profile

Follow
Jdmoney

2,085 Posts.

366

20/06/24

19:55

Post #: 74414283
Share

Originally posted by ReNova: ↑

For those who are worried about the end of 2026 for recruiting timeline.

Hey chatGPT are there any examples of oncology drugs that have been bought out straight after preliminary data in a open label phase 1 clinical trial has been released?

ChatGPT: Yes, there are several examples of oncology drugs that have been acquired after promising preliminary data from open-label Phase 1 clinical trials. Pharmaceutical companies often seek to acquire innovative cancer therapies early in their development based on encouraging early-stage data. Here are a few notable examples:

Loxo Oncology and Bayer:
Drug: LOXO-292 (later named selpercatinib)
Acquisition: Loxo Oncology was acquired by Eli Lilly for approximately $8 billion in 2019, following promising early clinical data, including Phase 1 results.
Details: LOXO-292 showed promising activity against RET fusion-positive cancers in Phase 1 trials, attracting significant interest and leading to the acquisition.

Juno Therapeutics and Celgene:
Drug: JCAR017 (later named lisocabtagene maraleucel or liso-cel)
Acquisition: Celgene acquired Juno Therapeutics for $9 billion in 2018.
Details: The acquisition was driven by positive early-stage data from open-label trials showing the efficacy of JCAR017, a CAR T-cell therapy, in treating B-cell malignancies.

ArQule and Merck:
Drug: ARQ 531
Acquisition: Merck acquired ArQule for $2.7 billion in 2019.
Details: ARQ 531, a BTK inhibitor, showed promising results in Phase 1 trials for treating B-cell malignancies, prompting Merck to make the acquisition.

Immunomedics and Gilead Sciences:
Drug: Sacituzumab govitecan (Trodelvy)Acquisition: Gilead Sciences acquired Immunomedics for $21 billion in 2020.
Details: Early Phase 1/2 data showed significant efficacy in triple-negative breast cancer, leading to the acquisition.

These acquisitions illustrate the high value placed on early promising data in the oncology field and the strategic importance of acquiring innovative therapies to strengthen pharmaceutical companies' oncology portfolios.

I have not checked the details, apparently AI can hallucinate, but the response is encouraging nonetheless.

Expand

I'm not sure how correct chatgpt is.

immunomedics got bought out just after accelerated approval

https://www.pharmaceutical-technology.com/news/gilead-sciences-acquires-immunomedics/?cf-view

RAC Price at posting: $1.87 Sentiment: None Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Trump is President Again: What Does This Mean for Crypto?

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: Australian market set to open slightly lower following a mixed session on Wall Street | November 12, 2024

PDN

Paladin cuts back uranium production guidance for FY25 based on hiccups at Langer Heinrich

There are more pages in this discussion • 93 more messages in this thread...

First 2219 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.53		Change -0.050(3.17%)		Mkt cap ! $259.9M

Open	High	Low	Value	Volume
$1.58	$1.59	$1.51	$174.6K	113.0K

Buyers (Bids)

No.	Vol.	Price($)
1	2372	$1.53

Sellers (Offers)

Price($)	Vol.	No.
$1.59	141	1

View Market Depth

No.	Vol.	Price($)
1	2372	1.525
2	14459	1.520
1	660	1.515
1	11000	1.505
2	10030	1.500

Price($)	Vol.	No.
1.585	141	1
1.620	2192	2
1.630	6499	2
1.640	4440	2
1.660	20000	1

Last trade - 16.10pm 11/11/2024 (20 minute delay)

RAC (ASX) Chart

RAC media coverage, page-2219

Trump is President Again: What Does This Mean for Crypto?

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: Australian market set to open slightly lower following a mixed session on Wall Street | November 12, 2024

Paladin cuts back uranium production guidance for FY25 based on hiccups at Langer Heinrich

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RAC media coverage, page-2219

Top Stories

Trump is President Again: What Does This Mean for Crypto?

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: Australian market set to open slightly lower following a mixed session on Wall Street | November 12, 2024

Paladin cuts back uranium production guidance for FY25 based on hiccups at Langer Heinrich

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News